1. Home
  2. DNLI vs VYX Comparison

DNLI vs VYX Comparison

Compare DNLI & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • VYX
  • Stock Information
  • Founded
  • DNLI 2013
  • VYX 1881
  • Country
  • DNLI United States
  • VYX United States
  • Employees
  • DNLI N/A
  • VYX N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • VYX
  • Sector
  • DNLI Health Care
  • VYX
  • Exchange
  • DNLI Nasdaq
  • VYX Nasdaq
  • Market Cap
  • DNLI 2.1B
  • VYX 1.8B
  • IPO Year
  • DNLI 2017
  • VYX N/A
  • Fundamental
  • Price
  • DNLI $15.43
  • VYX $13.31
  • Analyst Decision
  • DNLI Strong Buy
  • VYX Strong Buy
  • Analyst Count
  • DNLI 15
  • VYX 5
  • Target Price
  • DNLI $33.62
  • VYX $14.20
  • AVG Volume (30 Days)
  • DNLI 2.0M
  • VYX 1.5M
  • Earning Date
  • DNLI 11-05-2025
  • VYX 08-07-2025
  • Dividend Yield
  • DNLI N/A
  • VYX N/A
  • EPS Growth
  • DNLI N/A
  • VYX N/A
  • EPS
  • DNLI N/A
  • VYX 7.32
  • Revenue
  • DNLI N/A
  • VYX $2,677,000,000.00
  • Revenue This Year
  • DNLI N/A
  • VYX N/A
  • Revenue Next Year
  • DNLI $802.87
  • VYX N/A
  • P/E Ratio
  • DNLI N/A
  • VYX $1.81
  • Revenue Growth
  • DNLI N/A
  • VYX N/A
  • 52 Week Low
  • DNLI $10.57
  • VYX $7.55
  • 52 Week High
  • DNLI $33.33
  • VYX $15.34
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 56.61
  • VYX 53.76
  • Support Level
  • DNLI $14.52
  • VYX $12.49
  • Resistance Level
  • DNLI $16.20
  • VYX $13.77
  • Average True Range (ATR)
  • DNLI 0.70
  • VYX 0.41
  • MACD
  • DNLI -0.01
  • VYX -0.01
  • Stochastic Oscillator
  • DNLI 62.44
  • VYX 66.23

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

Share on Social Networks: